Following the first U.S. data presented on the Medtronic CoreValve System in patients treated via the transfemoral approach, Medtronic, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE